How COVID-19 has affected Medtronic, Stryker, Johnson & Johnson’s shares over the last month

Despite bans on elective orthopedic procedures, large device companies have successfully pivoted to weather the COVID-19 pandemic.

Advertisement

Here’s how Medtronic, Stryker and Johnson & Johnson shares have fluctuated over the last month.

Note: Becker’s is using final numbers at market close for each day unless otherwise noted.

Medtronic:
April 1: $84.11
April 6: $94.06
April 13: $99.52
April 20: $101.54
April 27: $100.76
Percent change: 19.8 percent

Stryker:
April 1: $144.67
April 6: $165.66
April 13: $172.08
April 20: $184.72
April 27: $191.96
Percent change: 32.69 percent

Johnson & Johnson (DePuy Synthes)
April 1: $128.81
April 6: $139.76
April 13: $139.77
April 20: $151.67
April 27: $154.29
Percent change: 19.78 percent

More articles on surgery centers:
Life after ramp-up: How COVID-19 will change ASCs forever
3 ASC nurses join COVID-19 front lines in New York
4 hospitals, health systems opening ASCs

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.